Tandem Diabetes Care (TNDM) FCF Margin (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly FCF Margin came in at 14.63% in Q2 2026, down 862.0% on a YoY basis from 1.92% in Q2 2025, and down 1527.92% quarter-over-quarter from 1.02% in Q1 2026.
Powered by 
Analysis
Tandem Diabetes Care (TNDM) FCF Margin (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported FCF Margin for 14 consecutive years, with 14.63% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin fell 862.0% year-over-year to 14.63%; the trailing twelve-month figure through Jun 2026 stood at 2.63% (down 186.0% YoY), and the FY2025 full-year result was 2.92%, down 345.0% from the prior year.
- FCF Margin retreated to 14.63% in Q2 2026 per TNDM's latest filing, from 1.02% in the prior quarter.
- Across five years, FCF Margin topped out at 8.83% in Q3 2024 and bottomed at 16.03% in Q1 2023.
- Historically, FCF Margin has averaged 2.78% across 5 years, with a median of 2.74% in 2022.
- The sharpest annual moves came in 2023 and 2024: FCF Margin tumbled 2237 bps in 2023, then surged 1171 bps in 2024.
- Over 5 years, FCF Margin stood at 0.09% in 2022, then plunged by 7308 bps to 6.31% in 2023, then jumped by 143 bps to 2.71% in 2024, then plunged by 60 bps to 1.07% in 2025, then tumbled by 1469 bps to 14.63% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 14.63%, 1.02%, and 1.07% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.73% |
| 10 | Tandem Diabetes Care | 1.26 Bn | 804.14 Mn | 144.78 Mn | -14.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14.63% |
| Mar 31, 2026 | 1.02% |
| Dec 31, 2025 | 1.07% |
| Sep 30, 2025 | 1.67% |
| Jun 30, 2025 | -6.01% |
| Mar 31, 2025 | -9.59% |
| Dec 31, 2024 | 2.71% |
| Sep 30, 2024 | 8.83% |
| Jun 30, 2024 | -5.29% |
| Mar 31, 2024 | -6.50% |
| Dec 31, 2023 | -6.31% |
| Sep 30, 2023 | -2.88% |
| Jun 30, 2023 | -6.99% |
| Mar 31, 2023 | -16.03% |
| Dec 31, 2022 | 0.09% |
| Sep 30, 2022 | 5.00% |
| Jun 30, 2022 | -2.60% |
| Mar 31, 2022 | 6.34% |
| Dec 31, 2021 | 6.61% |
| Sep 30, 2021 | 17.29% |